GREM1 and epilepsy: Here we have shown that our gliacentric Drosophila model of Dup15q epilepsy continues to be a robust tool for the evaluation of new compounds specifically targeted to this disorder, where pharmacoresistant epilepsy is a major factor in the quality of life of these individuals.